Hare D L, Davis C R
Department of Cardiology, Austin Hospital, Melbourne, Australia.
J Psychosom Res. 1996 Apr;40(4):379-86. doi: 10.1016/0022-3999(95)00612-5.
Assessing the effect of interventions on quality of life in cardiac patients lacks sensitivity because there is no specifically validated scale for measuring depression in cardiac patients. A questionnaire of 35 items (selected for face validity) was given to 246 cardiac outpatients (age 59.3 +/- 14.1 years, 159 male, 87 female). The Beck Depression Scale was then administered, followed by blinded clinical rating of depression. The item scores were subjected to common factor analysis. Internal consistency was assessed using alpha reliability coefficients and clinical validity using Spearman correlation coefficients. The final scale consisted of 26 items (alpha reliability coefficient 0.90) in 2 robust dimensions and 7 subscales. The scale correlated well with clinical rating and with the Beck Depression Scale, but without the marked skewness of the latter. The behavior of the new Cardiac Depression Scale suggests that it will be an excellent measure for studies of outcome in cardiac patients.
评估干预措施对心脏病患者生活质量的影响缺乏敏感性,因为目前尚无专门用于测量心脏病患者抑郁程度的经过验证的量表。向246名心脏病门诊患者(年龄59.3±14.1岁,男性159名,女性87名)发放了一份包含35个项目的问卷(基于表面效度选择)。随后使用贝克抑郁量表进行评估,并由专业人员对抑郁情况进行盲法临床评分。对项目得分进行共同因素分析。使用α信度系数评估内部一致性,使用斯皮尔曼相关系数评估临床效度。最终量表由26个项目组成(α信度系数为0.90),分为2个主要维度和7个子量表。该量表与临床评分以及贝克抑郁量表相关性良好,但没有后者明显的偏态。新的心脏病抑郁量表的表现表明,它将是研究心脏病患者预后的一项出色指标。